 |
The German healthcare market is the largest in Europe and one of the biggest worldwide;
it is also one of the most complicated. The new AMNOG legislation has dramatically
increased hurdles to market access for pharmaceutical companies. Furthermore, for
many companies, there is a significant language barrier, as little reliable information is
available in English.
PRMA Consulting is delighted to announce a three-part modular webinar, to be presented
in English, covering the German healthcare system and the impact of the AMNOG
legislation. Each session consists of a 1 hour presentation followed by 30 minutes for
questions and discussion. The sessions are presented by native German experts with
in-depth knowledge of the German healthcare system who have already run successful
workshops on AMNOG for national and international audiences. |
 |
|
 |
Monika Behrens
A senior consultant at PRMA Consulting, Monika worked for over
14 years at GSK in Germany, and before that for one of the biggest German sickness funds. Monika has hosted many AMNOG workshops for international audiences. |
|
|
|
 |
Dr Andreas Guhl
A director of PRMA Consulting, Andreas has frequently been invited by the German Pharmaceutical Industry Association (BPI) to give presentations on AMNOG.
Andreas will also be leading a conference workshop on the AMNOG legislation
with Germany's top payors on 28 and 29 September 2011 in Düsseldorf.
Download the program of events |
|
|
|
 |
Dr Peter Kolominsky-Rabas
Director of the Interdisciplinary Centre for Health Technology Assessment and Public Health, University of Erlangen-Nuremberg; former Director for Health Economics at IQWiG.
Guest speaker on Module 2, part 2 |
|
|
|
 |
Wednesday 5 October 2011, 17:00 BST
Introduction to the German healthcare system. Who are the (new) stakeholders and decision-makers in Germany? |
|
|
|
 |
Wednesday 12 October 2011, 17:00 BST
Strategic insights into AMNOG processes and timelines. Scientific advice by the G-BA. Preparing for submission of a benefit dossier. Choice of appropriate comparative therapy. |
|
|
|
 |
Wednesday 26 October 2011, 17:00 BST
Pricing and negotiations. Impact on healthcare systems outside Germany. The arbitration processes. |
|
|
|
